HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling.

Abstract
Bombesin/gastrin-releasing peptide (BN/GRP) antagonists RC-3940-II and RC-3940-Et, and growth hormone-releasing hormone (GHRH) antagonists MZ-J-7-118 and RC-J-29-18 inhibit the growth of human androgen-independent PC-3 and DU-145 prostate cancers in nude mice. Additive inhibitory effects were observed after treatment with both classes of analogs. In the present study, we investigated the effects of these antagonists on intracellular signalling pathways of protein kinase C (PKC), mitogen activated protein kinases (MAPK) and c-fos and c-jun oncogenes that are involved in tumour cell proliferation. In PC-3 tumours, antagonists of BN/GRP and GHRH decreased significantly the expression of PKC isoforms alpha (alpha), eta (eta) and zeta (zeta) and increased that of delta (delta) PKC protein. MAPK was not detectable. In DU-145 tumours, which constitutively express MAPK, all treatments strongly decreased the levels of p42/44 MAPK. Treatment with the antagonists tended to reduce m-RNA for c-jun in both tumour models. In proliferation assays in vitro, inhibitors of PKC and MAPK diminished growth of DU-145 and PC-3 cells. These findings suggest that antagonists of BN/GRP and GHRH inhibit the growth of androgen-independent prostate cancer by affecting intracellular signalling mechanisms of PKC, MAPK and c-jun.
AuthorsAnton Stangelberger, Andrew V Schally, Jozsef L Varga, Marta Zarandi, Ren-Zhi Cai, Benjamin Baker, Brian D Hammann, Patricia Armatis, Celia A Kanashiro
JournalEuropean journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 41 Issue 17 Pg. 2735-44 (Nov 2005) ISSN: 0959-8049 [Print] England
PMID16291086 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Neoplasm Proteins
  • Growth Hormone-Releasing Hormone
  • Protein Kinase C
  • Mitogen-Activated Protein Kinases
  • Bombesin
Topics
  • Analysis of Variance
  • Blotting, Western
  • Bombesin (antagonists & inhibitors)
  • Cell Communication
  • Cell Line, Tumor
  • Cell Proliferation
  • Genes, fos (physiology)
  • Genes, jun (physiology)
  • Growth Hormone-Releasing Hormone (antagonists & inhibitors)
  • Humans
  • Male
  • Mitogen-Activated Protein Kinases (metabolism)
  • Neoplasm Proteins (antagonists & inhibitors, metabolism)
  • Prostatic Neoplasms (metabolism, pathology, prevention & control)
  • Protein Kinase C (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: